SCHEMBL7092244

SCHEMBL7092244

O=C(OBr)c1cc(=O)c2ccccc2o1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.68
USP2 O75604 1/20 0.68
CSNK2A2 P19784 1/20 0.68
PTGS1 P23219 1/20 0.68
CSNK2B P67870 1/20 0.68
CSNK2A1 P68400 1/20 0.68
CSNK2A3 Q8NEV1 1/20 0.68
MAPT P10636 3/20 0.65
MAOB P27338 2/20 0.65
GAA P10253 1/20 0.65
KMT2A Q03164 6/20 0.60
POLB P06746 3/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
PKM P14618 1/20 0.56
NPSR1 Q6W5P4 1/20 0.56
LMNA P02545 1/20 0.56
MEN1 O00255 4/20 0.56
NPC1 O15118 3/20 0.56
RAB9A P51151 3/20 0.56
MAOA P21397 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3397825 0.85 MAPT (0.68) KDM4EUSP2CSNK2A2PTGS1CSNK2B
SCHEMBL29463595 0.85 MAPT (0.68) KDM4EUSP2CSNK2A2PTGS1CSNK2B
SCHEMBL29393797 0.83 AKR1B1 (0.70) KDM4EUSP2CSNK2A2PTGS1CSNK2B
SCHEMBL3359780 0.81 MAOB (0.80) KDM4EUSP2CSNK2A2PTGS1CSNK2B
SCHEMBL30285083 0.81 MAOB (0.80) KDM4EUSP2CSNK2A2PTGS1CSNK2B
SCHEMBL29394263 0.81 MAPT (0.63) KDM4EUSP2CSNK2A2PTGS1CSNK2B
SCHEMBL27625791 0.81 MAPT (0.63) KDM4EUSP2CSNK2A2PTGS1CSNK2B
SCHEMBL29569747 0.81 KDM4E (0.74) KDM4EUSP2CSNK2A2PTGS1CSNK2B
Chromocarb SCHEMBL29355904 0.81 KDM4E (1.00) KDM4EUSP2CSNK2A2PTGS1CSNK2B
Chromocarb SCHEMBL432304 0.81 KDM4E (1.00) KDM4EUSP2CSNK2A2PTGS1CSNK2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1353915-A2 THERAPEUTIC CHROMAN COMPOUNDS AstraZeneca AB (SE) 2003-10-22 EP disclosed
WO-2002055014-A2 THERAPEUTIC CHROMAN COMPOUNDS ASTRAZENECA AB (SE) 2002-07-18 WO disclosed